Ciliopathies

Gene: PRKCSH

Amber List (moderate evidence)

PRKCSH (protein kinase C substrate 80K-H)
EnsemblGeneIds (GRCh38): ENSG00000130175
EnsemblGeneIds (GRCh37): ENSG00000130175
OMIM: 177060, Gene2Phenotype
PRKCSH is in 6 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Comment when marking as ready: Potential phenotypic overlap with ciliopathies.
Created: 6 May 2020, 10:12 a.m. | Last Modified: 6 May 2020, 10:12 a.m.
Panel Version: 0.112

Crystle Lee (Victorian Clinical Genetics Services)

I don't know

Not a ciliopathy gene.

PMID: 12529853; Li 2003: Reported 6 ADPLD families.
PMID: 19876928; Gunay-Aygun 2009: PRKCSH encodes for hepatocystin and is not ciliary proteins; involved in the ER processing of proteins
PMID: 21856269; Janssen 2011: 2 hit mechanism required for formation of cysts. Germline variant + LoH of PRKCSH, therefore is recessive at the cellular level.

UniProt: "Required for efficient Polycystin 1 biogenesis and trafficking to the plasma membrane of the primary cilia"
Created: 6 May 2020, 1:08 a.m. | Last Modified: 6 May 2020, 1:08 a.m.
Panel Version: 0.103

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Polycystic liver disease 1 (MIM#174050)

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Victorian Clinical Genetics Services
Phenotypes
  • Polycystic liver disease 1 (MIM#174050)
OMIM
177060
Clinvar variants
Variants in PRKCSH
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

6 May 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: prkcsh has been classified as Amber List (Moderate Evidence).

6 May 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: PRKCSH were changed from to Polycystic liver disease 1 (MIM#174050)

6 May 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: PRKCSH were set to 19876928

6 May 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: PRKCSH were set to 19876928

6 May 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: PRKCSH were set to

6 May 2020, Gel status: 2

Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of pathogenicity for gene: PRKCSH was changed from to Other

6 May 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: PRKCSH was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

6 May 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: prkcsh has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: PRKCSH was added gene: PRKCSH was added to Ciliopathies_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: PRKCSH was set to Unknown